Evaluate alternative revolutionary reimbursement models to craft a sustainable cell and gene therapy business model

Webinar: Evaluate alternative revolutionary reimbursement models to craft a sustainable business model

Speakers:
David Senior: Senior Vice President, Market Economics at AmerisourceBergen
Heather McDonald: Vice President, Market Access for CGT + Digital at Bayer
Burcu Kazazoglu Taylor: Senior Director, Global Value and Access at Novartis Gene Therapies
Michael Sherman: Executive Vice President and Chief Medical Officer at Point 32

Contact our team

See cell and gene therapy solutions

Connect with our cell and gene therapy team

Schedule some time with our cell and gene therapy experts today. We look forward to hearing from you.

Contact us